| Name | Title | Contact Details |
|---|---|---|
Bryan Marcotte |
VP, Practice Platforms and Corporate Applications | Profile |
Demarco Smalls |
Chief Information Officer (CIO) | Profile |
Izhar Mujaddidi |
Vice President, Chief Information Security Officer | Profile |
Dan Sheehan |
Executive Vice President and Chief Information Officer | Profile |
Lydia Barron |
SVP and CTO | Profile |
The Synapse Group is a Burlington, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VTI Corp. is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Spectranetics is dedicated to managing every lead and eradicating restenosis and amputation. We do this by helping physicians, patients, and hospitals maximize cardiovascular health. Our company is committed to inventing, selling, and supporting technology that enables success during the most challenging minimally invasive cardiovascular procedures. We provide expert physician training, including the only lead removal simulator in the industry, as well as extensive patient and physician education. The Company’s Lead Management (LM) division is dedicated to helping physicians safely manage every lead. We provide the expert tools, training and ongoing support – including the only available lead extraction simulator – that allow physicians precision, control and versatility while extracting leads, so they can focus more on the patient’s overall status while generating positive outcomes. The Vascular Intervention (VI) division is dedicated to helping physicians address the challenges of peripheral and coronary artery disease. We provide expert tools, training, ongoing support, and patient education so that you can help eradicate restenosis and amputation
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
Chicago Dentist- Providing Excellent Dental Care is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.